Articles dans des revues avec comité de lecture (45)
  1. 13. Dubois, N., Crompot, E., Meuleman, N., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2020). Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles. Frontiers in oncology, 10, 1422. doi:10.3389/fonc.2020.01422
  2. 14. Wojdacz, T. K., Amarasinghe, H. H., Kadalayil, L., Beattie, A., Forster, J., Blakemore, S. S., Parker, H., Bryant, D., Larrayoz, M., Clifford, R., Robbe, P., Davis, Z. Z., Else, M., Howard, D. D., Stamatopoulos, B., Steele, A., Rosenquist, R., Collins, A., Pettitt, A. A., Hillmen, P., Plass, C., Schuh, A., Catovsky, D., Oscier, D. G., Rose-Zerilli, M. M., Oakes, C. C., & Strefford, J. J. (2019). Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: Results from 3 UK clinical trials. Blood Advances, 3(16), 2474-2481. doi:10.1182/bloodadvances.2019000237
  3. 15. Alexandri, C., Stamatopoulos, B., Rothé, F., Bareche, Y., Devos, M., & Demeestere, I. (2019). MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries. Scientific reports.
  4. 16. Chi, V. L. D., Garaud, S., De Silva, P., Thibaud, V., Stamatopoulos, B., Berehad, M., Gu-Trantien, C., Krayem, M., Duvillier, H., Lodewyckx, J. N., Willard-Gallo, K., Sibille, C., & Bron, D. (2019). Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC cancer, 19(1), 81. doi:10.1186/s12885-019-5276-2
  5. 17. Stamatopoulos, B., Smith, T. B., Crompot, E., Pieters, K., Clifford, R., Mraz, M., Robbe, P., Burns, A., Timbs, A., Bruce, D., Hillmen, P., Meuleman, N., Mineur, P., Firescu, R., Maerevoet, M., De Wilde, V., Efira, A., Philippé, J., Verhasselt, B., Offner, F., Sims, D., Heger, A., Dreau, H., & Schuh, A. (2018). The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results of a multicenter study. Clinical cancer research. doi:10.1158/1078-0432.CCR-18-0133
  6. 18. Burns, A., Alsolami, R., Becq, J., Stamatopoulos, B., Timbs, A., Bruce, D., Robbe, P., Vavoulis, D. D., Clifford, R., Cabes, M., Dreau, H., Taylor, J. A., Knight, S. J. L., Mansson, R., Bentley, D., Beekman, R., Martín-Subero, J. I., Campo, E., Houlston, R. S., Ridout, K. E., & Schuh, A. C. (2017). Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups. Leukemia. doi:10.1038/leu.2017.311
  7. 19. Crompot, E., Van Damme, M., Pieters, K., Vermeersch, M., Perez-Morga, D., Mineur, P., Maerevoet, M., Meuleman, N., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2017). Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B-cells from apoptosis, enhance their migration and induce gene expression modifications. Haematologica, 102(9), 1594-1604. doi:10.3324/haematol.2016.163337
  8. 20. Stamatopoulos, B., Antoniou, P., Mason, J., Dreau, H., Schuh, A., Timbs, A., Bruce, D., Smith, T., Clifford, R., Robbe, P., Burns, A., Vavoulis, D. D., & Lopez, L. (2017). Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia. Leukemia, 31(4), 837-845. doi:10.1038/leu.2016.307
  9. 21. Eyre, T. A., Clifford, R., Bloor, A., Boyle, L., Roberts, C., Cabes, M., Collins, G. P., Devereux, S., Follows, G., Fox, C. C., John, G. G., Hillmen, P., Hatton, C. S. R. C., Littlewood, T. J., McCarthy, H., Murray, J., Pettitt, A. A., Soilleux, E., Stamatopoulos, B., Love, S. S., Wotherspoon, A., & Schuh, A. (2016). NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome. British journal of haematology, 175(1), 43-54. doi:10.1111/bjh.14177
  10. 22. Van Damme, M., Crompot, E., Meuleman, N., Maerevoet, M., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2016). Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance. Clinical Epigenetics, 8, 132. doi:10.1186/s13148-016-0298-y
  11. 23. Andre, T., Najar, M., Stamatopoulos, B., Pieters, K., Pradier, O., Bron, D., Meuleman, N., & Lagneaux, L. (2015). Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells. Cancer immunology and immunotherapy, 64(2), 213-224. doi:10.1007/s00262-014-1623-y
  12. 24. Stamatopoulos, B., Van Damme, M., Crompot, E., Dessars, B., El Housni, H., Mineur, P., Meuleman, N., Bron, D., & Lagneaux, L. (2015). Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients. Molecular medicine. doi:10.2119/molmed.2014.00214
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>